DK1113797T3 - Anvendelse af duloxetin til behandling af fibromyalgi - Google Patents

Anvendelse af duloxetin til behandling af fibromyalgi

Info

Publication number
DK1113797T3
DK1113797T3 DK99969026.6T DK99969026T DK1113797T3 DK 1113797 T3 DK1113797 T3 DK 1113797T3 DK 99969026 T DK99969026 T DK 99969026T DK 1113797 T3 DK1113797 T3 DK 1113797T3
Authority
DK
Denmark
Prior art keywords
duloxetine
fibromyalgia
treatment
naphthalenyloxy
propanamine
Prior art date
Application number
DK99969026.6T
Other languages
English (en)
Inventor
David Joel Goldstein
Smriti Iyengar
Rosa Marie Ademe Simmons
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1113797T3 publication Critical patent/DK1113797T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99969026.6T 1998-09-15 1999-09-10 Anvendelse af duloxetin til behandling af fibromyalgi DK1113797T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10037798P 1998-09-15 1998-09-15
PCT/US1999/020986 WO2000015223A1 (en) 1998-09-15 1999-09-10 Treatment of persistent pain

Publications (1)

Publication Number Publication Date
DK1113797T3 true DK1113797T3 (da) 2010-02-01

Family

ID=22279434

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99969026.6T DK1113797T3 (da) 1998-09-15 1999-09-10 Anvendelse af duloxetin til behandling af fibromyalgi

Country Status (15)

Country Link
US (1) US6596756B1 (da)
EP (1) EP1113797B1 (da)
JP (1) JP2002524513A (da)
CN (1) CN1149991C (da)
AT (1) ATE449603T1 (da)
AU (1) AU746887B2 (da)
BR (1) BR9913671A (da)
CA (1) CA2344057C (da)
CY (1) CY1110581T1 (da)
DE (1) DE69941712D1 (da)
DK (1) DK1113797T3 (da)
ES (1) ES2335067T3 (da)
PT (1) PT1113797E (da)
SI (1) SI1113797T1 (da)
WO (1) WO2000015223A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087938A1 (en) * 2001-07-31 2003-05-08 Robertson David W. Treatment of chronic pain with 3-heterocycloxy-and 3-cycloalkyloxy-3-phenylpropanamines
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
AU2003225206B2 (en) * 2002-04-24 2008-02-14 Forest Laboratories Holdings Limited Prevention and treatment of functional somatic disorders, including stress-related disorders
AU2003227519A1 (en) * 2002-05-30 2003-12-19 Head Explorer A/S The use of milnacipran for the treatment of tension-type headache
CN1678322A (zh) * 2002-08-29 2005-10-05 阿瑞科诺沃治疗有限公司 (4－(2－氟苯基)－6－甲基－2－(1－哌嗪基)噻吩并[2,3－d]嘧啶的新治疗用途
EP1565182A1 (en) * 2002-11-19 2005-08-24 Eli Lilly And Company Treatment of gastrointestinal disorders with duloxetine
US20100256179A1 (en) * 2004-03-26 2010-10-07 Ucb Pharma Gmbh Combination therapy for pain in painful diabetic neuropathy
US20050233980A1 (en) * 2004-04-20 2005-10-20 Boehringer Ingelheim International Gmbh CGRP-antagonist in combination with a serotonin-reuptake inhibitor for the treatment of migraine
CA2573122A1 (en) * 2004-07-24 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Use of compounds active on the sigma receptor for the treatment of mechanical allodynia
CN100362996C (zh) * 2004-10-14 2008-01-23 上海医药工业研究院 一种度洛西汀肠溶微丸胶囊及其制备方法
JP2007523213A (ja) * 2004-12-23 2007-08-16 テバ ファーマシューティカル インダストリーズ リミティド 医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法
EP1856087A1 (en) * 2005-03-08 2007-11-21 Teva Pharmaceutical Industries Limited Crystal forms of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine oxalate and the preparation thereof
WO2007005644A2 (en) * 2005-07-01 2007-01-11 Concert Pharmaceuticals Inc. Novel aryloxypropanamines
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
WO2007062119A1 (en) * 2005-11-23 2007-05-31 Auspex Pharmaceuticals, Inc. Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
MX2008001079A (es) * 2006-05-23 2008-03-19 Teva Pharma Polimorfos de hidrocloruro de duloxetina.
EA027836B1 (ru) 2006-06-15 2017-09-29 ЮСиБи ФАРМА ГМБХ Фармацевтическая комбинация для профилактики, облегчения и/или лечения приступов эпилепсии и ее применение
WO2008009665A1 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
TW200846003A (en) * 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
US8708961B2 (en) * 2008-01-28 2014-04-29 Medsolve Technologies, Inc. Apparatus for infusing liquid to a body
US8758779B2 (en) 2009-06-25 2014-06-24 Wockhardt Ltd. Pharmaceutical composition of duloxetine
HUE042593T2 (hu) * 2010-03-09 2019-07-29 Alkermes Pharma Ireland Ltd Alkoholnak ellenálló enterális gyógyszerkészítmények
TW201615191A (zh) * 2014-10-24 2016-05-01 朗齊生物醫學股份有限公司 氨氯地平藥物應用於癌症治療
JP2020029447A (ja) * 2018-06-25 2020-02-27 大原薬品工業株式会社 腸溶性高分子及び抗付着剤を含有する顆粒
JP7390830B2 (ja) * 2019-09-11 2023-12-04 日本食品化工株式会社 医薬活性化合物の苦味抑制剤及び苦味抑制方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956388A (en) 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
US5508276A (en) 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
ZA958725B (en) 1994-10-20 1997-04-16 Lilly Co Eli Treatment of disorders with duloxetine
RO117296B1 (ro) 1996-03-11 2002-01-30 Lilly Co Eli Metoda pentru tratarea sau prevenirea cistitei interstitiale
UA48219C2 (uk) * 1996-03-25 2002-08-15 Елі Ліллі Енд Компані Композиція для вгамування болю (варіанти) та спосіб вгамування болю
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
US6596756B1 (en) 2003-07-22
EP1113797B1 (en) 2009-11-25
WO2000015223A1 (en) 2000-03-23
EP1113797A4 (en) 2006-07-05
AU746887B2 (en) 2002-05-02
CN1149991C (zh) 2004-05-19
EP1113797A1 (en) 2001-07-11
CN1316904A (zh) 2001-10-10
ES2335067T3 (es) 2010-03-18
ATE449603T1 (de) 2009-12-15
CA2344057C (en) 2008-11-18
AU1197200A (en) 2000-04-03
BR9913671A (pt) 2001-06-05
PT1113797E (pt) 2009-12-21
JP2002524513A (ja) 2002-08-06
DE69941712D1 (de) 2010-01-07
CA2344057A1 (en) 2000-03-23
SI1113797T1 (sl) 2010-02-26
CY1110581T1 (el) 2015-04-29

Similar Documents

Publication Publication Date Title
DK1113797T3 (da) Anvendelse af duloxetin til behandling af fibromyalgi
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
EA200000351A1 (ru) Лечение кондуктивных нарушений
NO2008014I1 (no) Rotigotin (c)-5,6,7,8-tetrahydro-6-(propyl(2,2-tienyl)amino)-1-naftol
JP2002524513A5 (da)
EA199700208A1 (ru) Тиенил-, фурил-, пирролил- и дифенилсульфонамиды и их производные, модулирующие активность эндотелина
FR12C0052I2 (fr) Utilisation de dapoxetine, un inhibiteur selectif de recaptage de serotonine a action rapide, pour traiter un dysfonctionnement sexuel
ATE489101T1 (de) Wiederherstellung der gelenken mit mesenchymalen stammzellen
DE69905938T2 (de) Kombination von duloxetin mit nichtsteroid-entzündungshemmern für die behandlung von schmerz
DE69806498D1 (de) Behandlung von kontaktlinsen mit wässrigen, alkalicarbonat-haltigen lösungen
BR9603431A (pt) Método para tratar privação de abuso de substância
PT1257271E (pt) Utilizacao de pramipexole para o tratamento da dependencia de tabaco/nicotina
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
IS6575A (is) Hýdroxýfenýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
DE60014928D1 (de) Retinoide zur behandlung von emphysem
EP0756869A3 (en) Use of duloxetine or of N-alkyl-3-phenyl-(2-alkylthiophenoxy)-propylamines for treating attention-deficit/hyperactivity disorder
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
DE59202663D1 (de) Verwendung eines UV-Strahlers zur Behandlung von Oberflächen.
IS6563A (is) Hýdroxýfenýl-píperasinýl-metýl-bensamíðafleiður til að meðhöndla sársauka
EA200200948A1 (ru) Лечение псориаза
BR9708027A (pt) Métodos de tratamento ou prevenção de cistite entersticial
DE60220825D1 (de) Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks
EE9700350A (et) COMT-inhibiitorite uus kasutamine ja diabeetiliste vaskulaarsete häirete ärahoidmise meetod
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DK1560578T3 (da) Anvendelse af distrontiumsaltet af 3-[N,N-di(carboxymethyl)-amino]-3-cyano-4-carboxymethyl-thiophen-5-carboxylsyre til opnåelse af et lægemiddel beregnet til behandling af gastroduodenale smerter